4,050
Participants
Start Date
June 7, 2022
Primary Completion Date
August 5, 2022
Study Completion Date
August 31, 2023
COVID-19 Protein Subunit Recombinant Vaccine
SARS-CoV-2 RBD subunit recombinant protein, manufactured by PT. Bio Farma
Active Comparator
Covovax® COVID-19 vaccine is a protein-based vaccine candidate engineered from the genetic sequence of the first strain of the SARS-CoV-2 betacoronavirus
Faculty of Medicine Diponegoro University, Semarang
Fakultas Kedokteran Universitas Indonesia, Jakarta
Faculty of Medicine Universitas Hassanudin, Makassar
Faculty of Medicine Universitas Andalas, Padang
Lead Sponsor
Fakultas Kedokteran Universitas Indonesia
OTHER
Faculty of Medicine Universitas Diponegoro
UNKNOWN
Faculty of Medicine Universitas Andalas
UNKNOWN
Faculty of Medicine Universitas Hassanudin
UNKNOWN
PT Bio Farma
INDUSTRY